Insights
What can we expect from the new era of clinical trials in the UK?
23 Jan 2025It is hoped that changes to legislation on clinical trials in the UK will quicken the trial approvals process and foster innovation in trial design without compromising patient safety. The amending legislation has been made and will apply in early 2026.
Changes to UK medical devices regulation: What is on the horizon for 2025?
23 Jan 2025The Medicines and Healthcare products Regulatory Agency (MHRA) recently published a roadmap which sets out the revised timeline for implementing reforms to the UK's medical devices regulatory framework.
Economic Crime and Corporate Transparency Act 2023 - managing fraud risk and the failure to prevent offence
23 Jan 2025The Economic Crime and Corporate Transparency Act 2023 (the Act) is a pivotal piece of legislation, aimed at bolstering the UK's defences against fraud.
Pharmaceuticals and Life Sciences: what will 2025 bring?
12 Dec 2024As things quieten down for the end of the year (ha ha, one day maybe but not 2024!), it is good to reflect on what is next. In this article, we have pointed towards a few key developments to watch out for in 2025.
Court of Appeal rules on how to calculate damages in liability clause
12 Dec 2024Clarifying liability caps: Key lessons from the Topalsson v Rolls Royce case
Research and development subsidies - report into the £129 million grant funding to BioNTech for the life sciences sector
02 Dec 2024This blog examines the Subsidy Advice Unit (SAU) report into a proposed subsidy by the Department of Science Innovation and Technology (DSIT) to BioNTech UK Limited (BioNTech).
